Anti-PARK2 Antibody

Offered by Antibodies.com as part of its Parkinson's disease research reagents, this affinity-purified polyclonal reagent is raised in Rabbit against the E3 ubiquitin-protein ligase parkin encoded by the PARK2/PRKN gene. Supplied as an unconjugated antiserum at a working concentration of 1.0 mg/mL, it is formulated in PBS containing 0.1% sodium azide and 50% glycerol as a stabiliser, and is packaged in a 50 µL vial. The antibody is recommended for Western blot, immunohistochemistry and immunofluorescence workflows and has been validated on samples from Human, Mouse and Rat origin. According to the supplier listing, the immunoglobulin class is IgG and the preparation is polyclonal, so the reagent recognises multiple epitopes on the endogenous PARK2 target rather than a single defined clone. Researchers studying mitophagy, proteasomal substrate turnover or autosomal recessive juvenile Parkinson disease can use this antibody to detect total PARK2 protein levels in cell and tissue lysates, with the sodium azide preservative included for straightforward handling at 4 °C and the glycerol component providing cryoprotection for longer-term storage at −20 °C. As with all Antibodies.com primary antibodies, the product is intended for research use only and is supported by the vendor's standard quality assurance and worldwide shipping logistics network.